Topics

Articles

Acquisition of healthcare logistics company to play a role in delivery of pharma and biologic treatments

UPS Inks Deal for Bomi Group

Division will operate under SCHOTT Pharma AG & Co. KGaA

SCHOTT Creates Stand-alone Company for Pharma Business

, which provides strategy consultancy to pharma and healthcare providers that are embracing transformation. Based in the UK, Richard is a specialist in commercialization strategy; commercial evaluations and due diligence; strategic analytics and forecasting; brand performance management; lifecycle management strategy; pre-launch planning; competitive intelligence and market research.

Richard’s therapy area expertise includes cardiovascular and metabolic disease, renal disease, oncology and dermatology. Richard holds a PhD in cardiovascular disease from Cambridge University, an MBA from The Open University. He is a Chartered Biologist and a Member of the Royal Society of Biology.

 and has extensive expertise in providing advice to biopharma leaders from global to local country affiliate. Having worked in blue-chip pharma at Merck Sharp & Dohme (MSD) for many years in commercial roles at senior management and board-level positions, he is well acquainted with how a large multinational operates and some of the day-to-day complexities. During this time at MSD, he gained invaluable experience and reputation in several therapy areas including cardio & metabolic disease, neurology, pain, urology, oncology and anti-infectives. Building brands and commercializing assets is his forte.

How cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies

Rethinking Pharma Commercialization Models as Healthcare Evolves

Price tag for bivalent dose was $1.74 billion 

US Government Purchases 66 Million Doses of Moderna’s COVID-19 Booster Candidate 

New 154,000 square-foot center will house several of the pharma company’s business units

Astellas Reveals Plans for South San Fran Biotech Campus

Samsung Biologics Acquires Land for ‘Bio Campus II’

Focus on operational excellence is playing a major role in this effort, company says

Piramal Pharma Boosts API Services

CDMO’s Ireland campus will increase in capacity by 50% as a result

SK Pharmteco to Invest $35 Million toward Site Expansion

Expanded partnership revolves around hemophilia A therapeutics

Business and Finance